Andrea Paul

WORK HISTORY

EDUCATION

ABOUT ANDREA PAUL

Andrea Paul is an experienced life sciences attorney and former biotech executive who provides strategic counsel on a wide range of corporate matters to clients at WilmerHale.Andrea’s practice focuses on counseling life sciences clients across a broad range of issues, including securities laws, corporate governance, public offerings and other capital-raising transactions. She also assists clients with matters involving compensation and benefits, collaborations and licensing, and mergers and acquisitions (M&A).Prior to joining the firm, Andrea served as Chief Legal Officer and Corporate Secretary at Zentalis Pharmaceuticals, where she led the Legal, Corporate Secretary, Quality and IT functions. Prior to Zentalis, Andrea was the General Counsel and Corporate Secretary of LogicBio Therapeutics, Vice President, Legal at Akebia Therapeutics, and Senior Corporate Counsel at Momenta Pharmaceuticals. While in-house, Andrea played key roles in numerous significant transactions, including Akebia’s merger with Keryx Biopharmaceuticals, a variety of equity financings, royalty monetization, debt facilities, licensing/collaboration agreements and supply agreements.Andrea began her legal career at an AmLaw 50 firm and then an AmLaw 100 firm advising on public company disclosure, corporate governance, M&A, and a wide variety of financings, including initial public offerings, follow-ons, private investment in public equity offerings (PIPEs), at-the-market facilities (ATMs) and cross-border financings.A graduate of Harvard Law School, Andrea served as Managing Editor of Volume 121 of The Harvard Law Review. She received her BA in Art History from Columbia University (Columbia College).Andrea is a speaker on public company disclosure, financing and executive compensation as well as internal investigations.